Table 4.

Predictors of all-cause mortality among of BEST participants with advanced chronic systolic heart failure receiving care at the Veterans Affairs (VA) vs. non-VA hospitals

	Hazard ratio* (95% confidence interval); p value
	Non-veterans (n=1,216)	Veterans (n=898)
Age (every year increase)	1.01 (1.00 – 1.02); p=0.017	1.01 (0.999 – 1.02); p=0.080
African American	1.44 (1.10 – 1.89); p=0.008	1.14 (0.86 – 1.50); p=0.358
NYHA Class IV	1.43 (1.03 – 1.99); p=0.034	1.20 (0.58 – 1.68); p=0.285
Coronary artery disease	1.13 (0.89 – 1.42); p=0.321	1.33 (0.997 – 1.77); p=0.053
Diabetes mellitus	1.16 (0.93 – 1.45); p=0.180	1.13 (0.900 – 1.43); p=0.287
Hypertension	0.81 (0.65 – 1.00); p=0.050	1.10 (0.854 – 1.43); p=0.448
Atrial fibrillation	1.44 (1.15 – 1.81); p=0.001	1.09 (0.849 – 1.39); p=0.512
Peripheral arterial disease	1.70 (1.31 – 2.20); p<0.001	1.33 (1.03 – 1.72); p=0.028
Chronic kidney disease	1.51 (1.21 – 1.87); p<0.001	1.76 (1.38 – 2.23); p=<0.001
Bucindolol	0.89 (0.73 – 1.09); p=0.268	0.88 (0.706 – 1.10); p=0.270
Pulmonary edema	1.54 (1.16 – 2.04); p=0.003	1.60 (1.18 – 2.16); p=0.002
LV ejection fraction <20%	1.45 (1.17 – 1.79); p=0.001	1.61 (1.27 – 2.05); p<0.001
RV ejection fraction <20%	1.76 (1.33 – 2.33); p<0.001	0.91 (0.63 – 1.32); p=0.620